Mono Pharmacare Limited has paid a fine of ₹96760 imposed by the National Stock Exchange of India (NSE) for non-compliance with Regulation 31 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The penalty followed notices issued by the exchange on May 14, 2026, and June 01, 2026, regarding the delay in meeting the regulatory requirements.

The Board of Directors acknowledged the non-compliance and the subsequent fine during a meeting. The company stated that the delay was inadvertent and not intentional. Upon receiving the notices, the management immediately took corrective steps to ensure full compliance with the applicable provisions of the SEBI regulations.

Expressing concern over the lapse, the Board advised the management to strengthen internal compliance monitoring mechanisms. The directive aims to ensure timely filing of all statutory and regulatory requirements to prevent future occurrences.

The following table summarizes the key details of the regulatory action:

mono pharmacare Limited will convene an Extraordinary General Meeting (EGM) on June 30, 2026, to seek shareholder approval for the appointment of a statutory auditor and an independent director. The meeting is scheduled to commence at 11:00 A.M. IST via physical and video conferencing modes at the company's registered office in Ahmedabad.

The board proposes appointing M/s. R K Mergu & Co., Chartered Accountants (Firm Registration No. 136876W), to fill a casual vacancy created by the resignation of M/s. Kumbhat & Co. LLP. The new auditors will hold office until the conclusion of the ensuing Annual General Meeting and conduct the statutory audit for the financial year 2025-26.

Additionally, the company seeks to regularize the appointment of Ms. Nirmala Ranawat (DIN: 11309088) as an independent director. She was initially appointed as an additional director on June 3, 2026. If approved, she will hold office for a term of five consecutive years.

Shareholders can participate in the decision-making process through remote e-voting, which will be facilitated by CDSL. The e-voting period opens on June 27, 2026, at 11:00 A.M. and closes on June 29, 2026, at 5:00 P.M. The record date for determining eligibility is June 23, 2026.

Key Resolutions

Ms. Nirmala Ranawat is a Practicing Company Secretary with qualifications including FCS (ICSI), M.Com., CA-IPCC, and LL.B. She currently serves as a director in Goversphere India Private Limited and Wise Monkey Advisory Private Limited. She holds no shares in Mono Pharmacare Limited and is not related to any of the company's directors or key managerial personnel.